Rosenblum Silverman Sutton S F Inc Merck & Co., Inc. Transaction History

Rosenblum Silverman Sutton S F Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$73.18 - $82.95 $289,207 - $327,818	-3,952 Closed	0 $0
Q4 2019 Jan 24, 2020	SELL	$77.58 - $87.54 $4,965 - $5,602	-64 Reduced 1.59%	3,952 $359,000
Q2 2019 Jul 31, 2019	SELL	$69.84 - $81.59 $9,428 - $11,014	-135 Reduced 3.25%	4,016 $337,000
Q1 2019 Apr 25, 2019	SELL	$69.58 - $79.36 $5.45 Million - $6.21 Million	-78,285 Reduced 94.96%	4,151 $345,000
Q4 2018 Feb 06, 2019	BUY	$65.24 - $75.71 $5.13 Million - $5.96 Million	78,685 Added 2097.71%	82,436 $8.37 Million
Q3 2018 Nov 09, 2018	BUY	$57.69 - $67.84 $216,395 - $254,467	3,751 New	3,751 $266,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Rosenblum Silverman Sutton S F Inc , based on Form 13F filings with the SEC.

Stay updated on Rosenblum Silverman Sutton S F Inc with notifications on news.